doxazosin

Generic: doxazosin mesylate

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin mesylate
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 8 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-3143
Product ID 50090-3143_4e11209a-907e-4840-8413-2bc9922ea162
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075536
Listing Expiration 2026-12-31
Marketing Start 2014-12-05

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500903143
Hyphenated Format 50090-3143

Supplemental Identifiers

RxCUI
197628
UNII
86P6PQK0MU

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin mesylate (source: ndc)
Application Number ANDA075536 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 8 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (50090-3143-0)
  • 100 TABLET in 1 BOTTLE (50090-3143-1)
source: ndc

Packages (2)

Ingredients (1)

doxazosin mesylate (8 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4e11209a-907e-4840-8413-2bc9922ea162", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197628"], "spl_set_id": ["9b6170e7-814a-46ef-b068-cf3e6508d5e1"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-3143-0)", "package_ndc": "50090-3143-0", "marketing_start_date": "20211028"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (50090-3143-1)", "package_ndc": "50090-3143-1", "marketing_start_date": "20170927"}], "brand_name": "Doxazosin", "product_id": "50090-3143_4e11209a-907e-4840-8413-2bc9922ea162", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "50090-3143", "generic_name": "Doxazosin Mesylate", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "8 mg/1"}], "application_number": "ANDA075536", "marketing_category": "ANDA", "marketing_start_date": "20141205", "listing_expiration_date": "20261231"}